Oliver Van Oekelen, MD, PhD, discusses how S100A8/A9 in promotes T-cell exhaustion and limits responses to bispecific antibody therapy in multiple myeloma.
Oliver Van Oekelen, MD, PhD
Advertisement
Oliver Van Oekelen, MD, PhD is a bioinformatics-trained MD, PhD, working as an Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel hospital in New York City.
Articles by Oliver Van Oekelen, MD, PhD
Advertisement
Latest Updated Articles
Dr Van Oekelen on the Role of S100A8/A9 in Promoting T-Cell Exhaustion in Multiple MyelomaPublished: September 24th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5